BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE
What is the Trade Name for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE
BREZTRI
What is the Indication for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE
1 INDICATIONS AND USAGE BREZTRI AEROSPHERE is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Limitations of Use: BREZTRI AEROSPHERE is not indicated for the relief of acute bronchospasm or for the treatment of asthma [see Warnings and Precautions (5.1 , 5.2) ] . BREZTRI AEROSPHERE is a combination of budesonide, an inhaled corticosteroid (ICS); glycopyrrolate, an anticholinergic; and formoterol fumarate, a long-acting beta 2 -adrenergic agonist (LABA), indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). (1) Limitations of Use: Not indicated for the relief of acute bronchospasm or for the treatment of asthma. (1 , 5.1 , 5.2)